Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Aberrant plasma MMP and TIMP dynamics in Schistosoma - Immune reconstitution inflammatory syndrome (IRIS).

Goovaerts O, Mwinzi PNM, Muok EMO, Ceulemans A, Colebunders R, Kestens L.

PLoS Negl Trop Dis. 2018 Aug 8;12(8):e0006710. doi: 10.1371/journal.pntd.0006710. eCollection 2018 Aug.

2.

Impact of Mothers' Schistosomiasis Status During Gestation on Children's IgG Antibody Responses to Routine Vaccines 2 Years Later and Anti-Schistosome and Anti-Malarial Responses by Neonates in Western Kenya.

Ondigo BN, Muok EMO, Oguso JK, Njenga SM, Kanyi HM, Ndombi EM, Priest JW, Kittur N, Secor WE, Karanja DMS, Colley DG.

Front Immunol. 2018 Jun 18;9:1402. doi: 10.3389/fimmu.2018.01402. eCollection 2018.

3.
4.

Association between CD4+ T-lymphocyte counts and fecal excretion of Schistosoma mansoni eggs in patients coinfected with S. mansoni and human immunodeficiency virus before and after initiation of antiretroviral therapy.

Muok EM, Simiyu EW, Ochola EA, Ng'ang'a ZW, Secor WE, Karanja DM, Mwinzi PN.

Am J Trop Med Hyg. 2013 Jul;89(1):42-5. doi: 10.4269/ajtmh.13-0045. Epub 2013 May 13.

5.

Mechanism of anemia in Schistosoma mansoni-infected school children in Western Kenya.

Butler SE, Muok EM, Montgomery SP, Odhiambo K, Mwinzi PM, Secor WE, Karanja DM.

Am J Trop Med Hyg. 2012 Nov;87(5):862-7. doi: 10.4269/ajtmh.2012.12-0248. Epub 2012 Sep 17.

6.

Integrated community-directed intervention for schistosomiasis and soil transmitted helminths in western Kenya - a pilot study.

Mwinzi PN, Montgomery SP, Owaga CO, Mwanje M, Muok EM, Ayisi JG, Laserson KF, Muchiri EM, Secor WE, Karanja DM.

Parasit Vectors. 2012 Aug 31;5:182.

7.

Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial.

Obonyo CO, Muok EM, Mwinzi PN.

Lancet Infect Dis. 2010 Sep;10(9):603-11. doi: 10.1016/S1473-3099(10)70161-4. Epub 2010 Aug 10.

PMID:
20705516
8.

Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.

Black CL, Muok EM, Mwinzi PN, Carter JM, Karanja DM, Secor WE, Colley DG.

J Infect Dis. 2010 Aug 15;202(3):399-405. doi: 10.1086/653828.

9.

Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.

Black CL, Mwinzi PN, Muok EM, Abudho B, Fitzsimmons CM, Dunne DW, Karanja DM, Secor WE, Colley DG.

PLoS Negl Trop Dis. 2010 Mar 23;4(3):e637. doi: 10.1371/journal.pntd.0000637.

10.

Short report: Childhood coinfections with Plasmodium falciparum and Schistosoma mansoni result in lower percentages of activated T cells and T regulatory memory cells than schistosomiasis only.

Muok EM, Mwinzi PN, Black CL, Carter JM, Ng'ang'a ZW, Gicheru MM, Secor WE, Karanja DM, Colley DG.

Am J Trop Med Hyg. 2009 Mar;80(3):475-8. Erratum in: Am J Trop Med Hyg. 2009 May;80(5):877. Mouk, Erick M O [corrected to Muok, Erick M O]. Am J Trop Med Hyg. 2009 Aug;81(2):370.

11.

T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment.

Watanabe K, Mwinzi PN, Black CL, Muok EM, Karanja DM, Secor WE, Colley DG.

Am J Trop Med Hyg. 2007 Oct;77(4):676-82.

Supplemental Content

Loading ...
Support Center